ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Internal Medicine

Top Internal Medicine Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IAN WAGGETT MD

Internal Medicine

3,741

$216K

197
166 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $64

VIRGINIA KEEFE HASSETT MD

Internal Medicine

3,722

$181K

200
151 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $64

EDWARD KHALIL MD

Internal Medicine

3,715

$226K

262
213 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $64

DANIEL DAVIES DO

Internal Medicine

3,689

$210K

274
218 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $64

STEPHEN KIRK M.D.

Internal Medicine

3,685

$205K

214
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $64

JOSEPH SAVAGE M.D.

Internal Medicine

3,654

$381K

232
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $64

ELIZABETH BRADLEY MD

Internal Medicine

3,642

$261K

279
249 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $64

BELINDA CASTOR M.D.

Internal Medicine

3,638

$265K

228
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $64

PHAT NGUYEN D.O.

Internal Medicine

3,637

$220K

313
214 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $64

PETER LUNDQUIST MD

Internal Medicine

3,621

$232K

219
163 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $64

THET HAN AUNG M.D

Internal Medicine

3,621

$174K

302
179 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $64

MARY TANZER MD

Internal Medicine

3,588

$200K

219
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $64

MAIRENI CRUZ MD

Internal Medicine

3,541

$126K

289
194 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $64

CHARLES CARRIER MD

Internal Medicine

3,411

$189K

244
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $64

IRA SCHWARTZ MD

Internal Medicine

3,409

$221K

279
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $64

DIANE FLAMBURIS MD

Internal Medicine

3,331

$248K

188
169 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $64

EDWARD YOURTEE MD

Internal Medicine

3,309

$235K

211
179 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $64

HILLARY CONKLING M.D.

Internal Medicine

3,309

$181K

257
235 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $64

REBECCA PACE DO

Internal Medicine

3,302

$169K

172
108 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $64

JEFFREY REISERT DO

Internal Medicine

3,289

$273K

217
185 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $64

GREGORY MORRISSEY DO

Internal Medicine

3,252

$191K

198
145 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $64

MARY BROOKS MD

Internal Medicine

3,248

$195K

185
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $64

PAMELA SCHULTZE MD

Internal Medicine

3,244

$193K

256
217 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $64

SANA ULLAH M.D.

Internal Medicine

3,224

$188K

257
139 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $64

SUSHAMA JAMPANI M.D.

Internal Medicine

3,210

$207K

206
175 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank